Drug Database
Back to search

Poland· PL-100416890

Miglustat Dipharma

A miglustat product containing miglustatum, registered in Poland by Dipharma Arzneimittel GmbH. The same ATC class is registered in 18 of our 19 countries.

ATC A16AX06

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMiglustat DipharmaATCA16AX06REGISTER NO.PL-100416890PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about miglustatumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Miglustat is registered in 18 of 19 countries.

Countries holding a registration under ATC A16AX06 (miglustat), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose
Search miglustat products by name

Miglustat · ATC A16AX06

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of miglustat costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Miglustat · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$225.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Miglustatum
Manufacturer
Dipharma Arzneimittel GmbH
Country
Poland (PL)
ATC code
A16AX06
ATC class
Miglustat
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for miglustat.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check miglustat against other medicinesHow interaction checks work

Miglustat · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • ImigluceraseA16AB02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Miglustat in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All miglustat products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Miglustat G.L.
  • Bulgaria · Миглустат G.L.
  • Cyprus · Miglustat Accord
  • Czechia · Miglustat Accord
  • Germany · Miglustat Accord, Miglustat Axunio
  • Denmark · Miglustat Bluefish, Miglustat Waymade
  • Spain · Miglustat Accord, Miglustat Waymade
  • Finland · Miglustat Accord, Miglustat Waymade
  • France · Miglustat Accord, Miglustat Bluefish
  • United Kingdom (Northern Ireland) · Miglustat Accord Healthcare, Miglustat Dipharma
  • Iceland · Miglustat Dipharma, Opfolda
  • Italy · Miglustat Accord, Miglustat Waymade
  • Liechtenstein · Miglustat Dipharma, Opfolda
  • Netherlands · Miglustat G.L., Miglustat Waymade
  • Norway · Miglustat Bluefish, Miglustat Dipharma
  • Portugal · Miglustato Accord
  • Romania · Miglustat Accord
  • Sweden · Miglustat, Miglustat Bluefish
  • Slovakia · Miglustat Accord, Miglustat G.L. Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/99f8e82b-d718-47a6-a421-37f93591614a
GET /v1/drugs/99f8e82b-d718-47a6-a421-37f93591614a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "100 mg",
  "packaging": "Rpz ¦ EU/1/18/1346/001 ¦ 131357\n84 kaps. w blistrze\nRpz ¦ EU/1/18/1346/002 ¦ 143616\n84 kaps. w blistrze perforowanym\nRpz ¦ EU/1/18/1346/003 ¦ 152691\n84 kaps. w blistrze",
  "substance": "Miglustatum 100 mg",
  "common_name": "Miglustatum",
  "pl_product_id": "100416890",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about miglustat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console